Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia (Q38102578)

28 August 2017

title

Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia (English)

1 reference

28 August 2017

Noa Tal

1 reference

28 August 2017

Chen Shochat

1 reference

28 August 2017

Ifat Geron

1 reference

28 August 2017

Dani Bercovich

1 reference

28 August 2017

Shai Izraeli

1 reference

28 August 2017

publication date

27 April 2013

1 reference

Cellular and Molecular Life Sciences

28 August 2017

published in

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

365-378

1 reference

Leukaemia -- a developmental perspective

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Lymphocide: cytokines and the control of lymphoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7 in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The human IL-7 receptor gene: deletions, polymorphisms and mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Stimulation of B-cell progenitors by cloned murine interleukin-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin 2 (IL-2) and interleukin 7 (IL-7) reciprocally induce IL-7 and IL-2 receptors on gamma delta T-cell receptor-positive intraepithelial lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin 7 is produced by murine and human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver: implications for extrathymic T cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Visualization and identification of IL-7 producing cells in reporter mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Characterization of the thymic IL-7 niche in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The interleukin-7 receptor gene is at 5p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-7 receptor expression: intelligent design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Expression and function of the interleukin 7 receptor in murine lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Ets-1 maintains IL-7 receptor expression in peripheral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Ephrinb1 and Ephrinb2 are associated with interleukin-7 receptor α and retard its internalization from the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Structural reorganization of the interleukin-7 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin 7 independent development of human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Determination of lymphoid cell fate is dependent on the expression status of the IL-7 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

STAT5 in B cell development and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-7: physiological roles and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

PI3K: downstream AKTion blocks apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Requirement for RORgamma in thymocyte survival and lymphoid organ development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Human thymic stromal lymphopoietin preferentially stimulates myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A role for thymic stromal lymphopoietin in CD4(+) T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

B-1 B cell development in the fetus and adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin‐7 induces the association of phosphatidylinositol 3‐kinase with the α chain of the interleukin‐7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7–induced signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

STAT5 activation underlies IL7 receptor-dependent B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Ralpha signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

JAK mutations in high-risk childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Interleukin-7 is a growth factor for Sézary lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Therapeutic potential of JAK2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Expression analysis and specific blockade of the receptor for human thymic stromal lymphopoietin (TSLP) by novel antibodies to the human TSLPRα receptor chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Suppression of IL7Rα Transcription by IL-7 and Other Prosurvival Cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1337-X

Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice.

21 January 2018

1 reference

12 December 2020

TSLP signaling network revealed by SILAC-based phosphoproteomics

1 reference

12 December 2020

Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity

1 reference

12 December 2020

Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein

1 reference

12 December 2020

Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction

1 reference

12 December 2020

The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis

1 reference

12 December 2020

JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3' kinase

1 reference

12 December 2020

Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain

1 reference

12 December 2020

Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells

1 reference

12 December 2020

IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway

1 reference

12 December 2020

Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice

1 reference

12 December 2020

Local blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cells

1 reference

12 December 2020

Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia.

1 reference

12 December 2020

Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia

1 reference

12 December 2020

Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.

1 reference

12 December 2020

A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells

1 reference

12 December 2020

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

12 December 2020

Defective T-cell receptor gamma gene rearrangement in interleukin-7 receptor knockout mice

1 reference

12 December 2020

Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy

1 reference

12 December 2020

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

1 reference

12 December 2020

Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours

1 reference

12 December 2020

Characterization of the human and murine IL-7 genes

1 reference

12 December 2020

Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias

1 reference

12 December 2020

A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency

1 reference

12 December 2020

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells

1 reference

12 December 2020

Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development

1 reference

12 December 2020

Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow

1 reference

12 December 2020

Fates of human B-cell precursors

1 reference

12 December 2020

Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2

1 reference

12 December 2020

10.1007/S00018-013-1337-X

Identifiers

DOI

1 reference

28 August 2017

1 reference